SCHEMBL42499

SCHEMBL42499

[CH2]C(F)CCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9725075 1.00
SCHEMBL8082557 1.00
SCHEMBL9429261 0.97 MAPT (0.48)
SCHEMBL9427876 0.97 MAPT (0.48)
SCHEMBL4317995 0.97
SCHEMBL7751087 0.97 MAPT (0.48)
SCHEMBL9427945 0.97 MAPT (0.48)
SCHEMBL5573758 0.97 MAPT (0.48)
SCHEMBL9427804 0.97 MAPT (0.48)
SCHEMBL477998 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024043242-A1 HEART FAILURE TREATMENT VIA CARDIOTONIC EFFECT BY TRPC3/6/7 CHANNEL ACTIVATION 国立大学法人九州大学 2024-02-29 WO disclosed
WO-2023233994-A1 PHARMACEUTICAL COMPOSITION AND AUTOPHAGY ACTIVATOR 国立大学法人京都大学 2023-12-07 WO disclosed
EP-4281072-A1 FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) VIFOR (INTERNATIONAL) AG (CH) 2023-11-29 EP disclosed
CN-116710091-A Membrane iron transporter inhibitors for the treatment of myelodysplastic syndrome (MDS) 威佛(国际)股份公司 2023-09-05 CN disclosed
CN-110785417-B Membrane iron transporter inhibitor salts 威佛(国际)股份公司 2023-05-23 CN disclosed
US-20220273634-A1 Ferroportin-Inhibitors For The Use In The Treatment Of Transfusion-Dependent Beta-Thalassemia (TDT) VIFOR (INTERNATIONAL) AG (CH) 2022-09-01 US disclosed
CN-114765955-A Methods and compositions for treating sickle cell disease with an iron transporter inhibitor (VIT-2763) 威佛(国际)股份公司 2022-07-19 CN disclosed
CN-114668761-A Novel ferroportin inhibitors 威佛(国际)股份公司 2022-06-28 CN disclosed
EP-3999059-A1 FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT) VIFOR (INTERNATIONAL) AG (CH) 2022-05-25 EP disclosed
EP-3999060-A1 FERROPORTIN-INHIBITORS FOR THE USE IN THE PREVENTION AND TREATMENT OF KIDNEY INJURIES VIFOR (INTERNATIONAL) AG (CH) 2022-05-25 EP disclosed
EP-0518636-A1 Liquid crystal compounds and compositions SANYO CHEMICAL INDUSTRIES LTD. (JP) 1992-12-16 EP disclosed
EP-0517498-A1 Liquid crystal compounds and compositions SANYO CHEMICAL INDUSTRIES LTD. (JP) 1992-12-09 EP disclosed
US-5160662-A Improved response times SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1992-11-03 US disclosed
US-5013847-A Insecticides, miticides, nematocides BASF AKTIENGESELLSCHAFT (DE) 1991-05-07 US disclosed
EP-0409634-A2 Liquid crystal compounds and optically active compounds SANYO CHEMICAL INDUSTRIES LTD. (JP) 1991-01-23 EP disclosed
US-4985590-A Optically active benzene derivatives and process for preparation thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-01-15 US disclosed
EP-0385692-A2 Optcally active compounds SANYO CHEMICAL INDUSTRIES LTD. (JP) 1990-09-05 EP disclosed
EP-0360622-A2 Novel optically active benzene derivatives, process for producing the same and liquid-crystalline composition containing said derivatives as liquid-crystalline compound and light switching elements SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-03-28 EP disclosed
EP-0288297-A2 Optically active benzene derivatives and process for preparation thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-10-26 EP disclosed
US-3933889-A 4,5-Cis-didehydro-PGF1.sub.α analogs THE UPJOHN COMPANY (US) 1976-01-20 US disclosed